Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

April 8, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
HCC - Hepatocellular Carcinoma
Interventions
RADIATION

Temporal change of fragmentomics of Circulating tumour DNA undergoing Stereotactic Body Radiation Therapy investigation

"Patients will have blood taking for Circulating tumour DNA (ctDNA) (20cc each) at Week 0 (before radiotherapy), Week 1 (during radiotherapy), Week 2 (after radiotherapy), Week 12 and Week 24.~Radiological assessment will be performed before radiotherapy, Week 12 (approximately 3 months post treatment) and Week 24-26 (approximately 6 months post treatment)."

Trial Locations (1)

Unknown

RECRUITING

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER